Carisma Therapeutics, Inc. (CARM)
0.0425
0.00 (0.00%)
USD |
OTCM |
Jan 09, 16:00
Carisma Therapeutics EPS Diluted (Quarterly): 1.066 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
| Oragenics, Inc. | -1.965 |
| NanoViricides, Inc. | -0.1045 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 44.72M |
| Revenue (Quarterly) | 45.25M |
| Total Expenses (Quarterly) | 0.533M |
| Enterprise Value | -0.2383M |
| Profit Margin (Quarterly) | 98.82% |
| Earnings Yield | 443.0% |
| Operating Earnings Yield | 611.0% |
| Normalized Earnings Yield | 479.51 |